Pharvaris PHVS
NASDAQ PHVS
$30.91 +0.01 (+0.02%)
As of: Oct 21, 2026 · 12:50 PM EDT

Pharvaris (PHVS) Operating Margin (2023 - 2026)

Updated

Analysis

Pharvaris (PHVS) Operating Margin (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 28.21%
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 37.86%
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 20.57%
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -133.21%
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 28.37%
10 Pharvaris 1.83 Bn 453.70 Mn - -2,385.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,385.32%
Sep 30, 2025 -0.01%
Jun 30, 2025 -3,783.72%
Mar 31, 2025 -1,573.44%
Sep 30, 2024 0.00%
Sep 30, 2023 -0.03%
Mar 31, 2023 -1,512.94%
API Access

Pharvaris Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=PHVS&period=max&api_key=YOUR_API_KEY